Home/Filings/4/0001437749-21-028129
4//SEC Filing

Reynolds Mark 4

Accession 0001437749-21-028129

CIK 0000832489other

Filed

Dec 7, 7:00 PM ET

Accepted

Dec 8, 5:20 PM ET

Size

5.1 KB

Accession

0001437749-21-028129

Insider Transaction Report

Form 4
Period: 2021-12-07
Reynolds Mark
Chief Financial Officer
Transactions
  • Award

    Stock Option (right to buy)

    2021-12-07+48,20048,200 total
    Exercise: $3.82Exp: 2031-12-07Common Stock (48,200 underlying)
Footnotes (1)
  • [F1]Stock option becomes exercisable in three equal annual installments of the first three anniversary dates of the grant.

Issuer

GeoVax Labs, Inc.

CIK 0000832489

Entity typeother

Related Parties

1
  • filerCIK 0001298237

Filing Metadata

Form type
4
Filed
Dec 7, 7:00 PM ET
Accepted
Dec 8, 5:20 PM ET
Size
5.1 KB